Skip to main content
Ambu logo

Ambu — Investor Relations & Filings

Ticker · AMBU ISIN · DK0060946788 LEI · 5299008W2A69WX355710 CO Manufacturing
Open in API
Filings indexed 1,333 across all filing types
Latest filing 2009-11-26 Director's Dealing
Country DK Denmark
Listing CO AMBU

About Ambu

https://www.ambu.com

Ambu is a global medical technology company that develops, manufactures, and markets single-use medical devices. A pioneer and market leader in single-use endoscopy, the company provides a broad portfolio of solutions for healthcare professionals across various clinical areas, including endoscopy, anesthesia, and patient monitoring. Its key products include the aScope™ line of single-use flexible endoscopes for pulmonology, gastroenterology, and urology, as well as video laryngoscopes. Ambu's solutions are designed to improve patient safety by eliminating the risk of cross-contamination associated with reusable devices, while also enhancing workflow efficiency in clinical environments by ensuring sterile, high-quality equipment is always available.

Recent filings

Filing Released Lang Actions
Director's Dealing 2009
Director's Dealing Classification · 99% confidence The document explicitly reports transactions involving shares in Ambu A/S made by an executive (President & CEO, Lars Marcher). It cites the Danish Securities Trading Act and details the nature of the transaction (Purchase of shares), the number of shares, and the trading date. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors).
2009-11-26 English
Director's Dealing 2009
Director's Dealing Classification · 99% confidence The document explicitly states it is a 'Reporting of transactions involving shares in Ambu A/S' and details a 'Purchase of shares' by an individual associated with the company (Bent Herlevesen, Corporate IT Manager). This transaction reporting is mandated by the Danish Securities Trading Act. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors), which is classified as 'Director's Dealing' (DIRS) in the provided schema, even though the individual is a manager rather than a director, as this category typically covers executive insider transactions.
2009-11-26 English
Regulatory Filings 2009
Regulatory Filings
2009-11-26 Danish
Management Reports 2009
Management Reports Classification · 99% confidence The document is titled "GPS FOUR FORRETNINGS-STRATEGI" (GPS Four Business Strategy) and details a multi-year strategic plan (starting in October 2009, aiming for 2013) focusing on product development, sales strengthening, efficiency, and acquisitions (GPS1, GPS2, GPS3, GPS4). It outlines goals for revenue, EBIT margin, and market position. This content is characteristic of a high-level strategic document or an Investor Presentation (IP) outlining future direction and performance targets, rather than a mandatory regulatory filing like a 10-K, an earnings release (ER), or a formal Audit Report (AR). Since it is a detailed presentation of strategy, market positioning, and future goals aimed at investors, Investor Presentation (IP) is the most appropriate classification. The length (7285 chars) supports a detailed document.
2009-11-25 English
Annual Report 2009
Annual Report
2009-11-25 Danish
Regulatory Filings 2009
Regulatory Filings
2009-10-15 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.